These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 560577)

  • 21. Clinical significance of urinary fibrin/fibrinogen degradation products (FDP) as measured by latex photometric immunoassay in renal diseases.
    Kaizu K; Ito Y; Uriu K; Eto S
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):29-34. PubMed ID: 8336397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary fibrin degradation products in childhood acute nephritis.
    Dawson KP
    N Z Med J; 1977 Oct; 86(597):332-4. PubMed ID: 272538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL; Francis CW; Knutson DW; Marder VJ
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Urinary fibrin/fibrinogen degradation products (FDP) in chronic glomerulonephritis].
    Shimamatsu K
    Fukuoka Igaku Zasshi; 1986 Sep; 77(9):480-9. PubMed ID: 3804170
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical significance of urinary fibrin/fibrinogen degradation products in renal disease. First report: Urinary fibrin/fibrinogen degradation products in primary glomerulonephritis (author's transl)].
    Miyamura S
    Nihon Jinzo Gakkai Shi; 1978 Jan; 20(1):67-78. PubMed ID: 650992
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical significance of urinary FDP-E measured by latex photometric immunoassay (LPIA) in the renal disease].
    Kaizu K; Ito Y; Uriu K; Komine N; Hashimoto O; Eto S
    Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):365-71. PubMed ID: 1875556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary fibrinogen and fibrin fragments in children with renal disease.
    Yoshioka K; Iseki T; Akano N; Uraoka Y; Miyata H; Maki S
    Nephron; 1982; 32(2):135-9. PubMed ID: 7177290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal vein fibrin degradation products (FDP's) in glomerulonephritis.
    Tomura S; Ideura T; Ida T; Osaka Y; Kuriyama R; Abe T; Takeuchi J
    Clin Nephrol; 1979 Dec; 12(6):248-53. PubMed ID: 527278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of urinary fibrin-fibrinogen degradation products in kidney transplantation.
    Exaire E; Flores-Izquierdo G; Ortiz F; Pizzuto J; Cruz M; Gutiérrez ML
    Arch Invest Med (Mex); 1978; 9(3):503-10. PubMed ID: 361009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic value of urinary fibrin degradation products.
    Schmitt E; Seyfarth M; Templin R; Schneider P; Klinkmann H
    Nephron; 1980; 25(1):25-9. PubMed ID: 6986037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The investigation on early diagnosis of the bladder tumor. I: A study on urinary cytology and urinary fibrin/fibrinogen degradation products (FDP) assay in patient with bladder tumor (author's transl)].
    Tanahashi T
    Nihon Hinyokika Gakkai Zasshi; 1979 May; 70(5):553-62. PubMed ID: 470263
    [No Abstract]   [Full Text] [Related]  

  • 32. Measurement of urinary fibrin/fibrinogen degradation products by latex photometric immunoassay.
    Kaizu K; Ito Y; Uriu K; Eto S
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):23-8. PubMed ID: 8336396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical significance of urinary fibrin-fibrinogen degradation products in renal disease].
    Umitsu Y
    Nihon Jinzo Gakkai Shi; 1976 Jun; 18(6):371-87. PubMed ID: 988340
    [No Abstract]   [Full Text] [Related]  

  • 34. [Diagnostic value of determining urinary fibrin split products in glomerulonephritis, pyelonephritis and graft rejection].
    Schmitt E; Seyfarth M; Templin R; Schneider P; Klinkmann H
    Z Urol Nephrol; 1978 Nov; 71(11):787-97. PubMed ID: 366978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of tissue-type plasminogen activator from a culture of calf kidney cells on hemostasis and fibrinolysis in experimental nephritis].
    Andreenko GV; Podorol'skaia LV; Serebriakova TN; Liaginskiĭ AV; Egorov BB
    Biull Eksp Biol Med; 1988 Oct; 106(10):424-6. PubMed ID: 3142531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary fibrin split products in human renal disease.
    Stiehm ER; Kuplic LS; Uehling DT
    J Lab Clin Med; 1971 May; 77(5):843-52. PubMed ID: 5557667
    [No Abstract]   [Full Text] [Related]  

  • 37. [Urinary crosslinked fibrin degradation products in various renal diseases].
    Kamitsuji H; Whitworth JA; Kincaid-Smith P
    Nihon Jinzo Gakkai Shi; 1986 Aug; 28(8):1137-43. PubMed ID: 3807046
    [No Abstract]   [Full Text] [Related]  

  • 38. [Urinary excretion of plasmin and fibrin-fibrinogen degradation products in various types of glomerulonephritis (author's transl)].
    Koyama A; Narita M; Ishida H; Fukao K; Tojo S
    Nihon Jinzo Gakkai Shi; 1979 Sep; 21(9):1037-46. PubMed ID: 160473
    [No Abstract]   [Full Text] [Related]  

  • 39. Factor VIII-related antigen determination in glomerular disease.
    Wang HL; Chen SJ; Zhang LN; Zhi LM; Dong DC; Chen QR; Zhou HZ
    Chin Med J (Engl); 1983 Feb; 96(2):117-20. PubMed ID: 6406168
    [No Abstract]   [Full Text] [Related]  

  • 40. Fibrin-fibrinogen degradation products in children with renal disease.
    Ambrus JL; Baliah T; Ambrus CM; Mink IB; Murphy GP
    N Y State J Med; 1974 Jul; 74(8):1396-402. PubMed ID: 4277485
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.